# A Phase 1 Study of SMP-100 in Normal Healthy Volunteers

> **NCT04296799** · PHASE1 · COMPLETED · sponsor: **Chengdu SciMount Pharmatech Co., Ltd.** · enrollment: 53 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** SMP-100
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04296799
- **Lead sponsor:** Chengdu SciMount Pharmatech Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-25
- **Primary completion:** 2021-07-26
- **Final completion:** 2021-08-06
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2022-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04296799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04296799, "A Phase 1 Study of SMP-100 in Normal Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04296799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*